Skip to main content
OpenTrials
Completed

NCT Number: NCT04335188

COVID-19 Registry Rhineland-Palatinate (Germany)

Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie

Ludwigshafen, RLP, 67063, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • In-patients fulfilling the following criteria:

SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study

Exclusion criteria

  • No explicit medical exclusion criteria are stated to avoid selection bias.

Treatment and study plan

Prospective oberservational registry

Other

Non interventional study.

Primary outcomes

  1. Chest x-ray

    Time frame: throughout study completion, in average 1.5 years

    presence of infiltrates

  2. Chest CT

    Time frame: throughout study completion, in average 1.5 years

    presence of infiltrates

  3. Supportive care - ICU

    Time frame: throughout study completion, in average 1.5 years

    number of patients with ICU treatment required

  4. Supportive care - oxygen therapy

    Time frame: throughout study completion, in average 1.5 years

    number of patients with oxygen therapy required

  5. Supportive care - ventilation

    Time frame: throughout study completion, in average 1.5 years

    number of patients with ventilation required

  6. Medication

    Time frame: throughout study completion, in average 1.5 years

    number of patients with medication changes

  7. Therapeutic strategies

    Time frame: throughout study completion, in average 1.5 years

    number of patients with ECMO required

  8. Lab parameters

    Time frame: throughout study completion, in average 1.5 years

    number of patients with significant changes in lab parameters

  9. Intra-hospital complications

    Time frame: throughout study completion, in average 1.5 years

    number of patients with complications during hospital stay

  10. Vital status at discharge

    Time frame: throughout study completion, in average 1.5 years

    vital status at discharge: alive, dead

Sponsors and collaborators

Lead sponsor

IHF GmbH - Institut für Herzinfarktforschung

Other

Collaborators

  • Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz

Registry information

Official study title

COVID-19 Registry Rhineland-Palatinate (Germany) - COVID-19 Disease Registry a National, Multicentre, Non-interventional, Prospective Observational Study

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Apr 6, 2020
Registry last updated
May 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.